Skip to main content
OpenTrials
Completed

NCT Number: NCT07813546

Comparion of Effects of Two Different Power Toothbrushes on Plaque and Gum Health

The goal of this clinical trial is to learn if powered toothbrushing with a side-to-side motion is more effective than powered toothbrushing with oscillating-rotation motion in removing dental plaque. It will also learn about the safety of power toothbrushing with both products. The main questions the study aims to answer are:

Does side-to-side power toothbrushing remove more dental plaque than oscillating-rotation toothbrushing? Does side-to-side power toothbrushing reduce symptoms of gingivitis better than oscillating-rotation toothbrushing?

Participants will:

Brush their teeth twice a day with either a side-to-side or oscillating-rotation power toothbrush Visit the clinic twice during the study: once at baseline and six weeks after the study starts.

Keep a diary of when they brushed their teeth

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–59 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Salus Research, Inc.

Fort Wayne, Indiana, 46825, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be in general good health
  • Be willing and physically able to carry out all study procedures and be available at all times required for participation
  • Be able to fully understand and comply with the written and verbal instructions provided
  • Provide written informed consent
  • Be willing to attend all study visits
  • Agree to return study materials at the required visit(s)
  • Between the ages of 18-59 years
  • Be a non-smoker
  • Have a minimum of 20 'scorable' teeth (excluding 3rd molars)
  • Have an average plaque score of >1.8 per Modified Plaque Index scoring with 3-6 hours of plaque accumulation
  • Have a gingival bleeding score of >1 on a minimum of 50 gingival sites per Gingival Bleeding Index
  • Be a regular manual toothbrush user

Exclusion criteria

  • Are pregnant or nursing per subject report
  • A medical or dental condition that would be unduly affected by participation in this study, per Investigator discretion
  • A medical condition requiring antibiotic pre-medication prior to dental appointments
  • Diagnosis of xerostomia
  • Oral or extra oral piercing that interferes with the ability to perform study procedures and/or clinical assessments in the mouth
  • Currently undergoing or requiring dental/periodontal treatment, or having had periodontal treatment in the six months preceding the study, where the subject's study participation could present an undue safety risk or obscure the evaluation of study endpoints, per Investigator/Examiner discretion
  • Oral surgery within the last 2 months
  • Currently using professionally dispensed bleaching products
  • A known allergy or sensitivity to products planned for use in this study
  • Unwilling to abstain from all other oral hygiene products other than those prescribed for the duration of the study
  • Participated in an oral care study within the previous 60 days
  • Employee or a relative of an employee of the Site clinical research department, dental school, or a dental products manufacturing, research or marketing firm
  • Dental student or dental professional
  • A cardiac pacemaker or implanted cardiac defibrillator
  • Insulin-Dependent Diabetes
  • Immunocompromised or Immune-impaired/suppressed.
  • Current use of antibiotic medications or use within 4 weeks of enrollment
  • Current use of prescription-dose anti-inflammatory medications or anticoagulants; (including aspirin > 81 mg daily)
  • Presence of advanced periodontal disease or excessive gingival recession, per Investigator/Examiner discretion
  • Heavy deposits of calculus, either supragingival and/or subgingival, per Investigator/Examiner discretion
  • Extensive crown or bridge work and/or rampant decay, per Investigator/Examiner discretion
  • Presence of orthodontic bands, wires or brackets
  • A professional prophylaxis within 4 weeks of the study

Treatment and study plan

oscillating-rotating powered toothbrush

Device

Oral-B iO Series 9

side-to-side powered toothbrush

Device

Sonicare 9900 Prestige

Primary outcomes

  1. Compare the reduction in gingival inflammation for side-to-side powered toothbrush to oscillating-rotating powered toothbrush.

    Time frame: 6 weeks

    Gingivitis is measured by Modified Gingival Index (MGI) (Lobene et al 1986) using six sites per tooth (distobuccal, buccal, mesiobuccal and distolingual, lingual, mesiolingual) where 0=absence of inflammation,

    • mild inflammation; slight change in color, little change in texture of the marginal or papillary gingival unit,
    • mild inflammation; criteria as shown above but involving the entire marginal or papillary gingiva,
    • moderate inflammation glazing, redness, edema, and/or hypertrophy of the marginal or papillary gingiva,
    • severe inflammation, marked redness, edema, and/or hypertrophy of the marginal or papillary gingiva, spontaneous bleeding, congestion or ulceration.

    Change in MGI will be calculated by subtracting follow-up MPI score from baseline MGI score. Differences in MGI will be compared between the two powered toothbrush groups.

Secondary outcomes

  1. Compare the reduction in gingival bleeding for side-to-side powered toothbrush to oscillating-rotating powered toothbrush.

    Time frame: 6 weeks

    Gingival bleeding is measured by Gingival Bleeding Index (GBI), (Van der Weijden et al, 1994) using six sites per tooth (distobuccal, buccal, mesiobuccal and distolingual, lingual, mesiolingual) where 0 = no bleeding,

    • = bleeding on gently probing,
    • = bleeding appears immediately upon gently probing,
    • = spontaneous bleeding which is present prior to probing.

    Change in GBI will be calculated by subtracting follow-up GBI score from baseline GBI score. Differences in GBI will be compared between the two powered toothbrush groups.

  2. Compare the reduction in surface plaque for side-to-side powered toothbrush to oscillating-rotating powered toothbrush.

    Time frame: 6 weeks

    Surface plaque is measured by Lobene and Soparkar Modified Quigley-Hein Plaque Index (MPI) using six sites per tooth (distobuccal, buccal, mesiobuccal and distolingual, lingual, mesiolingual) where 0=no plaque,

    • separate flecks of plaque at the cervical margin of the tooth,
    • a thin continuous band of plaque (up to 1 mm) at the cervical margin of the tooth,
    • a band of plaque wider than 1 mm covering less than one third of the crown of the tooth,
    • plaque covering at least one-third but less than two-thirds of the crown of the tooth,
    • plaque covering two-thirds or more of the crown of the tooth.

    Change in MPI will be calculated by subtracting follow-up MPI score from baseline MPI score. Differences in MPI will be compared between the two powered toothbrush groups.

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Philips Clinical & Medical Affairs Global

Industry

Registry information

Official study title

A Six-Week Randomized, Parallel Design Study to Compare the Effects of Philips Sonicare 9900 Prestige Versus an Oscillating-Rotating Power Toothbrush on Plaque and Gum Health

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Sep 10, 2026
Registry last updated
Sep 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.